Context sidebar

New on this website

13.12.2024

Summary report on authorisation – Tecartus®

Extension of therapeutic indication (01)

13.12.2024

Summary report on authorisation – Tibsovo®

First authorisation

12.12.2024

DHPC – Rabipur (virus rabiei inactivatus)

Berichte über Partikel nach der Rekonstitution - Empfehlungen zur Minimierung des Risikos für Partikel

11.12.2024

Summary report on authorisation – Trikafta®

Extension of therapeutic indication (03)

10.12.2024

Out-of-Stock – NovoSeven raumtemperaturstabiles Injektionspräparat

Befristete Bewilligung zum Vertrieb in niederländischer Aufmachung

06.12.2024

Summary report on authorisation – Qdenga®

First authorisation

06.12.2024

Summary report on authorisation – Zolgensma®

First authorisation

06.12.2024

Summary report on authorisation – Tegsedi®

First authorisation - no longer authorised

06.12.2024

Aufsichtsabgabe 2024 – Selbstdeklaration

Eingabefrist: 24. Januar 2025

05.12.2024

Swissmedic Journal

Latest edition
Swissmedic Journal November 2024

04.12.2024

Public consultation on ICH Guideline E6(R3) Annex 2 “Good Clinical Practice (GCP)” launched in Switzerland

With a deadline of 28 February 2025 for comments

04.12.2024

Public consultation for ICH Guideline M15 “General Principles for Model-Informed Drug Development” launched in Switzerland

Stakeholders in Switzerland have the possibility to comment on the draft of Guideline M15 “General Principles for Model-Informed Drug Development” until 28 February 2025
Permanent link of this page
www.swissmedic.ch/updates-en
News channel of this page
Newsletter
New on the website

Last modification 12.12.2024

Top of page